HSPA5 expression was significantly upregulated in 14 types of cancer, including cholangiocarcinoma, colon adenocarcinoma, esophageal carcinoma, diffuse large B cell lymphoma, pancreatic adenocarcinoma, and others. This evidence concerns the gene HSPA5 and cholangiocarcinoma.